Pharmacy Pearls: Update on Pharmacological Treatment for ObesityDecember 8th, 2023 | Pharmacy Pearls
In this edition of Pharmacy Pearls, you will find an update on weight loss medication. Specifically, this pearl highlights the recently approved medication ZepboundTM, which contains the same active ingredient, tirzepatide, as MounjaroTM but is now approved for weight loss instead of diabetes. There are still many unknowns with this medication- including exact cost and coverage, and availability. Some pharmacies in the area are reporting the ability to order, and some are not yet able to order it. We anticipate a great deal of patient interest in this medication and hope you find this information helpful.
As always, we welcome any questions or feedback you may have. Just email the Pharmacy Team.